|
Volumn 59 Suppl 6, Issue , 2001, Pages 769-773
|
Prevention of development of hepatocellular carcinoma from HCV-associated liver cirrhosis by multi-agents therapy including stronger-neo-minophagen C
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
CYSTEINE;
DRUG DERIVATIVE;
GLYCINE;
GLYCYRRHETINIC ACID;
HERBACEOUS AGENT;
JUZENTAIHOTO;
NEOMINOPHAGEN C;
SAIKO-KEISHI-TO;
SHOSAIKOTO GO KEISHIKASHAKUYAKUTO;
URSODEOXYCHOLIC ACID;
CLINICAL TRIAL;
DRUG COMBINATION;
HEPATITIS C;
HUMAN;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
LIVER TUMOR;
REVIEW;
RISK;
TREATMENT OUTCOME;
ANTI-INFLAMMATORY AGENTS;
CARCINOMA, HEPATOCELLULAR;
CLINICAL TRIALS;
CYSTEINE;
DRUG COMBINATIONS;
DRUG THERAPY, COMBINATION;
DRUGS, CHINESE HERBAL;
GLYCINE;
GLYCYRRHETINIC ACID;
HEPATITIS C;
HUMANS;
LIVER CIRRHOSIS;
LIVER NEOPLASMS;
RISK;
TREATMENT OUTCOME;
URSODEOXYCHOLIC ACID;
|
EID: 18744427128
PISSN: 00471852
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (3)
|
References (11)
|